CR Bard Inc. (NYSE: BCR) is a large market cap stock with a market cap of 16392.25. It is in the Medical Instruments & Supplies industry and sector Healthcare, with a current P/E of 43.97, a forward P/E of 19.7 and EPS of 5.06. At a stock price of 219.62 (-1.35%) it has a dividend yield of 0.47%.
EPS growth for the last five years have been -19.80%, more recently this last year it has grown by -52.90%. The next year growth is going to be about 11.18% and more long-term 10.87% after five years. EPS growth quarter over quarter is 413.20%. Sales growth for the past five years have been 4.70% and sales growth quarter over quarter is -63.30%.
For performance, CR Bard Inc. the past week has seen a gain of -3.82%. For the last month performance for CR Bard Inc. is -5.06%. While the last quarter is 4.15% and half year, 18.13%. Finally for the year, performance is 14.03%.
The 52-week high for CR Bard Inc., is at -8.17%, and for the 52-week low it comes to a value of 27.99%. The 20-day simple moving average is -3.50% and 8.91% for the 200-day simple moving average.
Volatility for the week is at 1.85%, and for the month it is 1.30%. CR Bard Inc., has a target price of 243.83.
In terms of debt, long term debt/equity is 1.01, and for total debt/equity CR Bard Inc. has 1.01. The gross margin is 62.50%, while operating margin is 14.10%, the profit margin is 9.10%. The current ratio is 2.4 and the quick ratio is 1.9.
Insider ownership is at 0.50%, with instituitional ownership at 92.50%. CR Bard Inc. has a payout ratio of 22.00%. With the total shares outstanding coming to 73.63. The shares float is 73.18, with the float short at 1.82%, with short ratio coming to 2.8.
In terms of returns, the return on assets see CR Bard Inc., get 6.30%, with its returns on investment at 6.40%. Return on equity is 21.40%. So will the investors see the target price of 243.83, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.